Seriously mannn, they do. Somebody knows something and they're buying lots of AMRN.
Rumor seems to be that Kelly Martin & Joe Zakrzewski are discussing options for the commercialization of the Anchor indication. Timing seems to work perfectly for both parties.
yeah, SR does and he interviewed an analyst
You didn't see seekingalpha, come one baby you are not in this world
of course i saw it. My place on this message board is to say "Dudes, somebody knows something, mannnn." every time there is a run. Everyone has there place here.
Pretty sure the IMS prescription data is out for February. Someone looking at new scripts for the drug and likey what they see.